A non-surgical treatment with Dr Allen’s Device keeps coming top for patients affected by kidney stones, prostate enlargement (BPH), lower urinary tract symptoms (LUTS), pelvic pain and coronary heart disease. The effectiveness of therapy is based on the ability of Dr Allen’s Device to address the cause of these non-cancerous conditions, see Origin of Chronic Diseases, https://en.wikipedia.org/wiki/Origin_of_Chronic_Diseases.
A new scientific article sheds light on the mental health benefits of this prostate treatment with Dr Allen’s Device during the coronavirus pandemic. Published in the Andrology Journal and titled “Benign Prostatic Hyperplasia and Chronic Prostatitis Thermobalancing Therapy can Prevent Sexual Dysfunction and Depression Linked to Medications: Importance during a Pandemic”, the medical article demonstrates clear advantages of Dr Allen’s Device and Thermobalancing therapy over all other treatments with prescribed medications and surgeries.
The study shows that the wearable Dr Allen’s Device effectively treats both the abnormal growth of the prostate, a common condition called benign prostatic hyperplasia (BPH), and chronic prostate inflammation, which is called chronic prostatitis or Chronic Pelvic Pain Syndrome (CP/CPPS). With absolutely no bad side effects, Dr Allen’s Device is good for men’s mental health, and has proven to be very much needed during the Covid-19 pandemic.
Kidney stone disease is non-malignant chronic condition, therefore should not be operated at this time of a pandemic, surgical treatments of urolithiasis, such as extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolithotomy (PCNL), should be suspended, states a recent medical article: “Impact of the COVID-19 pandemic on the urologist’s clinical practice in Brazil: a management guideline proposal for low- and middle- income countries during the crisis period”, by Carneiro with colleagues.
BPH and prostatitis medications are alarmingly dangerous
All medications for men with enlarged prostate and prostatitis cause serious health problems to a greater or lesser extent. Drugs belonging the α1-blockers group are associated with adverse reactions, abnormal ejaculation, dizziness, asthenia, intraoperative floppy iris syndrome and even dementia. Hormonal drugs are even worse: 5α-reductase inhibitors (5-ARIs) decrease libido, and cause gynecomastia, erectile dysfunction and sexual side effects, and even diabetes.
“Efficacy and Side Effects of Medicines Commonly Used to Treat Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia” medical review highlights the risks and disadvantages of prostate medications. This scientific study, published in the Frontiers in Pharmacology Journal in 2020, provides current comprehensive insights into the mechanisms of action, efficacy, and adverse reactions associated with the drugs most commonly used to treat the prostate, and suggests that individualized treatment plans are required with male approval of possible side effects.
Dr Allen’s Device is side effects free and helpful during a pandemic
Dr Simon Allen and Ariana Adjani invented Thermobalancing therapy with Dr Allen’s Device and were granted a patent by USPTO, confirming the uniqueness of this new therapeutic treatment. Dr Allen’s Device has been registered with the British Medical Healthcare Agency (MHRA) since 2010, so its safety is confirmed, regulated, and has been well tested over the decade.
The improvement of blood circulation in the affected prostate, heart or kidneys, i.e. the main treating factor in Dr Allen’s Device, is achieved by applying a unique and harmless thermoelement to the projection of organs. No batteries are involved as the thermoelement accumulates the emitted body heat becoming the source of energy itself.
The easy-to-use Dr Allen’s Device is a superb at-home treatment. It is a belt for prostate or kidney treatment or a shirt for coronary heart disease. It also minimizes the risk of virus transmission during a coronavirus pandemic by reducing the number of hospital visits and patient contact with different healthcare providers.
This is highly important during the Covid19 pandemic, as alarming information about problems associated with BPH treatment at hospitals is coming to light. The International Journal of Clinical Practice has published an article on “Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in ageing male” reporting that in March – April 2020, out of 18 BPH patients who were admitted and treated in a hospital, 10 men (i.e. 55.5%) got infected with the coronavirus, 2 of them were transferred to the intensive care unit and 1 man even died.
Fine Treatment makes Dr Allen’s Devices available across the world
Fine Treatment https://finetreatment.com/ is an innovative British healthcare company and an industry leader in non-surgical medical R&D with a clear focus on the improvement of health and wellbeing of people around the world. Fine Treatment is responsible for manufacturing and exclusive distribution of therapeutic Dr Allen’s Devices invented by Dr Simon Allen and Ariana Adjani.
Fine Treatment is a UK Department for International Trade (DIT) registered supplier to international buyers and makes its wearable therapeutic Dr Allen’s Devices available worldwide, with free international delivery on offer. Thousands of Fine Treatment customers across 100 countries have already benefited from this powerful prostate treatment.
